Rimon Gold Assets Ltd 13D and 13G filings for NeuroSense Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-09 4:00 pm Purchase |
2024-12-02 | 13G | NeuroSense Therapeutics Ltd. NRSN |
Rimon Gold Assets Ltd | 2,303,729 9.990% |
2,303,729 (New Position) |
Filing |